GlobeNewswire 2021-12-06 Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D., M.B.A. as Chief Financial Officer
GlobeNewswire 2021-11-04 Adverum Reports Third Quarter 2021 Results
GlobeNewswire 2021-10-09 Adverum Presents Clinical Data on ADVM-022 at the American Society of Retina Specialists 39th Annual...
GlobeNewswire 2021-10-01 Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile f...
GlobeNewswire 2021-09-27 Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences
GlobeNewswire 2021-09-09 Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation ...
GlobeNewswire 2021-08-23 Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulat...
GlobeNewswire 2021-08-05 Adverum Reports Second Quarter 2021 Results
GlobeNewswire 2021-07-22 Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema
GlobeNewswire 2021-07-01 Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs
GlobeNewswire 2021-06-24 Adverum Announces Changes to Management Team
GlobeNewswire 2021-06-01 Adverum Appoints CMO and CSO
GlobeNewswire 2021-05-12 Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
GlobeNewswire 2021-05-10 Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
GlobeNewswire 2021-05-06 Adverum Reports First Quarter 2021 Results
GlobeNewswire 2021-05-01 Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-...
GlobeNewswire 2021-04-28 Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with D...
GlobeNewswire 2021-04-27 Aligos Therapeutics Appoints James Scopa, J.D., MBA, to its Board of Directors
GlobeNewswire 2021-04-22 Adverum Files Investor Presentation Highlighting Significant Strategic Progress and Purpose-Built Bo...
GlobeNewswire 2021-04-21 Adverum Mails Letter to Stockholders Highlighting World-Class Board of Directors Overseeing Successf...
GlobeNewswire 2021-04-16 Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Thera...
GlobeNewswire 2021-04-15 Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team...
GlobeNewswire 2021-03-30 Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advance...
GlobeNewswire 2021-03-18 Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-03-17 Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...